Soverini S, De Benedittis C, Gnani A, Iacobucci I, Castagnetti F, Gugliotta G, et al. (2012). Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology. Philadelphia : American Association of Cancer Research [10.1158/1538-7445.AM2012-1884].
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology
SOVERINI, SIMONA;DE BENEDITTIS, CATERINA;Gnani A;IACOBUCCI, ILARIA;CASTAGNETTI, FAUSTO;GUGLIOTTA, GABRIELE;PAPAYANNIDIS, CRISTINA;CATTINA, FEDERICA;Russo D;PANTALEO, MARIA ABBONDANZA;ROSTI, GIANANTONIO;BACCARANI, MICHELE;MARTINELLI, GIOVANNI
2012
File in questo prodotto:
Eventuali allegati, non sono esposti
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
